NasdaqGS:RGENLife Sciences
Reassessing Repligen (RGEN) Valuation After A Steep Multi‑Month Share Price Pullback
Repligen stock reaction and recent performance
Repligen (RGEN) continues to trade in focus after recent share price moves, with the stock closing at $104.20 and sitting against a backdrop of mixed short- and longer-term returns.
Over the past week the stock fell about 10%, and it is down around 21% over the past month and 23% over the past 3 months, with the year-to-date return down roughly 37%.
See our latest analysis for Repligen.
With a 1-day share price return of 1.29% but a year-to-date...